IFNG and neoplasm: We found that CREKA-lipo-anti-IFNγ combined with cisplatin treatment increased the density of CD31+ tumour blood vessels and the distribution of endothelial junctional molecule VE-cadherin when compared with those by cisplatin alone, while lactate reversed the effects of CREKA-lipo-anti-IFNγ on blood vessels (Figure 6B).